|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Sung JJ, Lau JY, Goh KL and Leung WK; Asia
Pacific Working Group On Colorectal Cancer: Increasing incidence of
colorectal cancer in Asia: implications for screening. Lancet
Oncol. 6:871–876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Climent J, Dimitrow P, Fridlyand J, et al:
Deletion of chromosome 11q predicts response to anthracycline-based
chemotherapy in early breast cancer. Cancer Res. 67:818–826. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee Y, Kim M, Han J, et al: MicroRNA genes
are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee Y, Jeon K, Lee JT, Kim S and Kim VN:
MicroRNA maturation: stepwise processing and subcellular
localization. EMBO J. 21:4663–4670. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han J, Lee Y, Yeom KH, Kim YK, Jin H and
Kim VN: The Drosha-DGCR8 complex in primary microRNA processing.
Genes Dev. 18:3016–3027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee Y, Ahn C, Han J, et al: The nuclear
RNase III Drosha initiates microRNA processing. Nature.
425:415–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
10
|
Hutvagner G, McLachlan J, Pasquinelli AE,
Bálint E, Tuschl T and Zamore PD: A cellular function for the
RNA-interference enzyme Dicer in the maturation of the let-7 small
temporal RNA. Science. 293:834–838. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peters L and Meister G: Argonaute
proteins: mediators of RNA silencing. Mol Cell. 26:611–623. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parker JS and Barford D: Argonaute: A
scaffold for the function of short regulatory RNAs. Trends Biochem
Sci. 31:622–630. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: how many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Felli N, Fontana L, Pelosi E, et al:
MicroRNAs 221 and 222 inhibit normal erythropoiesis and
erythroleukemic cell growth via kit receptor down-modulation. Proc
Natl Acad Sci USA. 102:18081–18086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Huang H, Sun L, et al: MiR-21
indicates poor prognosis in tongue squamous cell carcinomas as an
apoptosis inhibitor. Clin Cancer Res. 15:3998–4008. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang S, Aurora AB, Johnson BA, et al: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2 and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
19
|
Huh JH, Kim TH, Kim K, et al:
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance
to ovarian cancer. Br J Cancer. 109:452–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang Y, Shen H, Li H, et al: miR-106a
confers cisplatin resistance by regulating PTEN/Akt pathway in
gastric cancer cells. Acta Biochim Biophys Sin (Shanghai).
45:963–972. 2013. View Article : Google Scholar
|
|
21
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan D, Zhang X, Chen X, et al: Bird's-eye
view on gastric cancer research of the past 25years. J
Gastroenterol Hepatol. 20:360–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu H, Wu H, Liu X, et al: Role of
MicroRNA miR-27a and miR-451 in the regulation of
MDR1/P-glycoprotein expression in human cancer cells. Biochem
Pharmacol. 76:582–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng F, Henson R, Lang M, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Colombo V, Lupi M, Falcetta F, Forestieri
D, D'Incalci M and Ubezio P: Chemotherapeutic activity of silymarin
combined with doxorubicin or paclitaxel in sensitive and
multidrug-resistant colon cancer cells. Cancer Chemother Pharmacol.
67:369–379. 2011. View Article : Google Scholar
|
|
26
|
Weinlander G, Kornek G, Raderer M, Hejna
M, Tetzner C and Scheithauer W: Treatment of advanced colorectal
cancer with doxorubicin combined with two potential
multidrug-resistance-reversing agents: high-dose oral tamoxifen and
dexverapamil. J Cancer Res Clin Oncol. 123:452–455. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Simon SM and Schindler M: Cell biological
mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci
USA. 91:3497–3504. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kopnin BP: Targets of oncogenes and tumor
suppressors: key for understanding basic mechanisms of
carcinogenesis. Biochemistry (Mosc). 65:2–27. 2000.
|
|
30
|
Frank NY, Margaryan A, Huang Y, et al:
ABCB5-mediated doxorubicin transport and chemoresistance in human
malignant melanoma. Cancer Res. 65:4320–4333. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen KG, Valencia JC, Gillet JP, Hearing
VJ and Gottesman MM: Involvement of ABC transporters in
melanogenesis and the development of multidrug resistance of
melanoma. Pigment Cell Melanoma Res. 22:740–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen KG, Szakács G, Annereau JP, et al:
Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB
5beta) of the ATP-binding cassette transporter gene ABCB 5 in
melanoma cells and melanocytes. Pigment Cell Res. 18:102–112. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wilson BJ, Schatton T, Zhan Q, et al:
ABCB5 identifies a therapy-refractory tumor cell population in
colorectal cancer patients. Cancer Res. 71:5307–5316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Theile D, Ketabi-Kiyanvash N, Herold-Mende
C, et al: Evaluation of drug transporters' significance for
multidrug resistance in head and neck squamous cell carcinoma. Head
Neck. 33:959–968. 2011. View Article : Google Scholar
|
